Innovative research has unveiled promising advancements in melanoma detection, which could significantly enhance diagnosis ...
The following is a summary of “Development of antibody levels and subsequent decline in individuals with vaccine induced and hybrid immunity to SARS-CoV-2,” published in the September 2024 issue of ...
Innovative research has unveiled promising advancements in melanoma detection, which could significantly enhance diagnosis and prognosis by identifying the disease at its earliest, most treatable ...
Staphylococcus aureus, mostly known from its antibiotic-resistant variant Methicillin-resistant Staphylococcus aureus (MRSA), ...
An international collaboration of researchers in Europe and the U.S. has identified a critical immune factor for host defense against Staphylococcus aureus, which could offer a potential explanation ...
In the human, the placenta is the predominant route of IgG transfer in the maternal-to-fetal direction; the immune protection provided by maternal antibodies is essential for newborns during the ...
IGM Biosciences has collaboration deal with Sanofi inked in 2022 and its stock has almost doubled in 2024 year to date. Read ...
Discover Genmab AS's groundbreaking patent for enhanced antibodies with a variant Fc domain, improving cancer treatment efficacy through innovative polypeptide technology.
Amsterdam, Netherlands) Innovative research has unveiled promising advancements in melanoma detection, which could ...
Many of these tests measure your body’s immune response to a variety of foods by testing the levels of certain antibodies in your blood, such as IgG and IgG4, after you’re exposed to various ...
Antibodies and related products are the fastest growing class of therapeutic agents. By analysing the regulatory approvals of IgG-based biotherapeutic agents in the past 10 years, we can gain ...
This new method, presented at the European Academy of Dermatology and Venereology (EADV) Congress 2024, uses tumour-specific profiling to detect antibodies unique to stage I and II melanoma patients.